Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -8570.05%, near the high end of its 5-year range (-28987.10%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-8570.05%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 551 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Candel Therapeutics, Inc.
Market Cap
$748.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-8570.05%
Market Cap
$756.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$731.98M
Operating Margin
-123601.69%
TTM Avg
-69568.65%
3Y Avg
-35191.57%
5Y Avg
-23714.64%
Market Cap
$773.03M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$777.34M
Operating Margin
-98.21%
TTM Avg
-366.21%
3Y Avg
-21871.64%
5Y Avg
-19485.10%
Market Cap
$762.06M
Operating Margin
-4974.74%
TTM Avg
-2487.37%
3Y Avg
-2487.37%
5Y Avg
-2487.37%
Market Cap
$770.34M
Operating Margin
-21.60%
TTM Avg
-15.14%
3Y Avg
-11.45%
5Y Avg
-3.99%
Market Cap
$722.43M
Operating Margin
-4908.21%
TTM Avg
-3903.83%
3Y Avg
-2635.01%
5Y Avg
-1845.37%
Market Cap
$718.41M
Operating Margin
19.61%
TTM Avg
25.44%
3Y Avg
21.88%
5Y Avg
18.67%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | $748.37M | 0.00% | 0.00% | 0.00% | -8570.05% |
| Design Therapeutics, Inc. (DSGN)vs › | $756.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $731.98M | -123601.69% | -69568.65% | -35191.57% | -23714.64% |
| Geron Corporation (GERN)vs › | $773.03M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -98.21% | -366.21% | -21871.64% | -19485.10% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $762.06M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
| Cytek Biosciences, Inc. (CTKB)vs › | $770.34M | -21.60% | -15.14% | -11.45% | -3.99% |
| Anteris Technologies Global Corp. (AVR)vs › | $722.43M | -4908.21% | -3903.83% | -2635.01% | -1845.37% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $718.41M | 19.61% | 25.44% | 21.88% | 18.67% |
| Mesa Laboratories, Inc. (MLAB)vs › | $788.35M | 9.00% | 7.11% | -27.53% | -16.39% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -26132.26% |
| 2022-09-30 | -28648.39% |
| 2022-06-30 | -28235.48% |
| 2022-03-31 | -28987.10% |
| 2021-12-31 | -24967.74% |
| 2021-09-30 | -25900.00% |
| 2021-06-30 | -17100.00% |
| 2021-03-31 | -15022.58% |
| 2020-12-31 | -19758.06% |
| 2020-09-30 | -8867.74% |
| 2020-06-30 | -8448.39% |
| 2020-03-31 | -7477.42% |
